Gene · 1294
Papers2,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of antimicrobial resistant Empedobacter from fresh meat and meat preparations. | Curr Res Food Sci | 2025 | 41080801 | PubTator, text mining | PubMed |
| Type VII Collagen Disorders Simplified. | Cutis | 2025 | 41056121 | PubTator, text mining | PubMed |
| Narrowing the Differential: A Unique Case of Dystrophic Epidermolysis Bullosa. | Case Rep Pediatr | 2025 | 41019009 | PubTator, text mining | PubMed |
| An International Online Survey on Oral Hygiene Issues in Patients with Epidermolysis Bullosa. | Dent J (Basel) | 2025 | 41002671 | PubTator, text mining | PubMed |
| Immune microenvironment and fibroblast subpopulation in diabetic wound healing. | iScience | 2025 | 40995117 | PubTator, text mining | PubMed |
| Sephardic origins revealed for rare skin disorder, recessive dystrophic epidermolysis bullosa, in individuals carrying the unique c.6527insC mutation. | J Med Genet | 2025 | 40992924 | PubTator, text mining | PubMed |
| Tissue and systemic inflammation in dystrophic epidermolysis bullosa: a systematic review and meta-analysis. | Orphanet J Rare Dis | 2025 | 40988071 | PubTator, text mining | PubMed |
Measurement properties of instruments used to measure health-related quality of life in pediatric and adults patients with inherited epidermolysis bullosa: A systematic review and meta-analysis protocol. | PLoS One | 2025 | 40971360 | PubTator, text mining | PubMed |
| miR-129-1-3p down-regulation promotes BAG cochaperone 3 (BAG3)-driven pro-fibrotic processes in primary fibroblasts from patients with recessive dystrophic epidermolysis bullosa. | Noncoding RNA Res | 2025 | 40970248 | PubTator, text mining | PubMed |
| Identifying novel genetic variants in epidermolysis Bullosa among Middle Eastern Arab Families: Insights from whole exome sequencing and computational analysis. | PLoS One | 2025 | 40956805 | PubTator, text mining | PubMed |
| Efficacy of Encorelane in Enhancing Barrier Function and Reducing Aging Signs in Sensitive Skin. | J Cosmet Dermatol | 2025 | 40952030 | PubTator, text mining | PubMed |
| Safety and Efficacy of Angiotensin Receptor Antagonists in Recessive Dystrophic Epidermolysis Bullosa. | Australas J Dermatol | 2025 | 40898775 | PubTator, text mining | PubMed |
| Inflammatory modulation by cord blood stem cells prevented digit deformation in recessive dystrophic epidermolysis bullosa. | Mol Ther | 2025 | 40883988 | PubTator, text mining | PubMed |
| Prademagene Zamikeracel: First Approval. | Mol Diagn Ther | 2025 | 40875177 | PubTator, text mining | PubMed |
| Contribution of HMGB1 to Keratinocyte inflammation in Recessive Dystrophic Epidermolysis Bullosa. | bioRxiv | 2025 | 40832291 | PubTator, text mining | PubMed |
| Skin irritation testing using human iPSCs derived 3D skin equivalent model. | PLoS One | 2025 | 40825023 | PubTator, text mining | PubMed |
| Genital Crohn's disease in pediatrics and genetic associations. | JPGN Rep | 2025 | 40814578 | PubTator, text mining | PubMed |
| SEDCYDO - SEGER - SEMO CONGRESS MADRID 2025, 8-10 MAY. Proceedings and Abstract. | Med Oral Patol Oral Cir Bucal | 2025 | 40767450 | PubTator, text mining | PubMed |
| SERPINH1 promotes malignant progression of laryngeal squamous cell carcinoma via COL7A1-mediated Wnt/β-catenin signaling. | Cell Signal | 2025 | 40752536 | PubTator, text mining | PubMed |
| Genetic profiling of epidermolysis bullosa in a large Brazilian cohort. | Clin Exp Dermatol | 2025 | 40701620 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1294/papers?page=5